arrow
V

Vittorio Fusco

University of Messina
H指数:30
被引数:3,074

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Possible Contribution of Oral Microbiota in the Osteonecrosis of the Jaw Induced by Zoledronate or Denosumab: A Preliminary Study

唑来膦酸或地诺单抗诱导的颌骨坏死中口腔微生物组的可能贡献:一项初步研究

2026-04-040
OAAI
Corrigendum to Evaluation of a context-aware chatbot using retrieval-augmented generation for answering clinical questions on medication-related osteonecrosis of the jaw [J. Craniomaxillofac. Surg. 53 (2025) 355-360]

勘误:关于使用检索增强生成技术评估面向药物相关颌骨坏死临床问题问答的情境感知聊天机器人的研究 [J. Craniomaxillofac. Surg. 53 (2025) 355-360]

2025-12-010
OAAI
Oral health status and quality of life in female patients receiving low dose bone-modifying agents for cancer treatment-induced bone loss: a single-center exploratory study

口腔健康状况及生活质量在因癌症治疗诱导骨流失而接受低剂量骨改良剂治疗的女性患者中的表现:一项单中心探索性研究

2025-10-310
OAAI
Oropharyngeal adverse drug reactions: knowledge, attitudes, and practice (KAP) among Italian healthcare professionals and students

口咽部药物不良反应:意大利医疗保健专业人员和学生的知识、态度和实践(KAP)

2025-04-110
OA
A Multi-Center Observation Study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in Patients with Osteoporosis, and Other Non-Malignant Bone Diseases, in Northwestern Italy over 16 Years
2024-09-251
OAAI
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

接种SARS-CoV-2疫苗可预防癌症患者COVID19的发病率、死亡率和后遗症

2022-08-0123
OAAI
Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR) (vol 19, 1215, 2019)
2020-02-172
OAAI
Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR)
2019-12-169
OAAI
Comments on Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
2015-05-1820
OAAI